University of Michigan Scleroderma Program — Ann Arbor, Michigan

University of Michigan Scleroderma Program is a clinical research site located in Ann Arbor, Michigan, United States 48016.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Michigan Scleroderma Program has participated in 3 clinical trials.

Therapeutic areas: Systemic Sclerosis, Scleroderma, Pulmonary Arterial Hypertension.

Sponsors: United Therapeutics, Actelion.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Michigan Scleroderma Program?

University of Michigan Scleroderma Program has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Michigan Scleroderma Program conducted?

University of Michigan Scleroderma Program has 3 clinical trials on record. Their work covers Systemic Sclerosis, Scleroderma, Pulmonary Arterial Hypertension.

Is University of Michigan Scleroderma Program accredited by Crixeo Health?

University of Michigan Scleroderma Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Michigan Scleroderma Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.